Spiro Rombotis
2007
In 2007, Spiro Rombotis earned a total compensation of $1.3M as President and Chief Executive Officer at Cyclacel Pharmaceuticals, a 27% decrease compared to previous year.
Compensation breakdown
| Bonus | $136,500 |
|---|---|
| Option Awards | $750,286 |
| Salary | $425,000 |
| Other | $20,964 |
| Total | $1,332,750 |
Rombotis received $750.3K in option awards, accounting for 56% of the total pay in 2007.
Rombotis also received $136.5K in bonus, $425K in salary and $21K in other compensation.
Rankings
In 2007, Spiro Rombotis' compensation ranked 3,288th out of 8,700 executives tracked by ExecPay. In other words, Rombotis earned more than 62.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,288 out of 8,700 | 62nd |
Division Manufacturing | 1,148 out of 3,314 | 65th |
Major group Chemicals And Allied Products | 214 out of 746 | 71st |
Industry group Drugs | 116 out of 546 | 79th |
Industry Pharmaceutical Preparations | 87 out of 364 | 76th |
Source: SEC filing on April 2, 2008.
Rombotis' colleagues
We found four more compensation records of executives who worked with Spiro Rombotis at Cyclacel Pharmaceuticals in 2007.
2007
Paul McBarron
Cyclacel Pharmaceuticals
Chief Operating Officer
2007
Judy Chiao
Cyclacel Pharmaceuticals
Vice President Clinical Development and Regulatory Affairs
2007
Greg Reyes
Cyclacel Pharmaceuticals
Senior Vice President Research
2007
John Womelsdorf
Cyclacel Pharmaceuticals
Vice President, Business Development
News
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2023 pay slips 13% to $661K
May 7, 2024
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2022 pay falls 43% to $764K
April 28, 2023
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2021 pay slips 5% to $1.3M
April 26, 2022
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2020 pay jumps 39% to $1.4M
April 29, 2021
Cyclacel Pharmaceuticals CEO Spiro Rombotis' 2019 pay jumps 35% to $1M
May 12, 2020